| Fisher Dental Llc | |
|
106 5th St Ne Aliceville AL 35442-2200 | |
| (205) 373-8726 | |
| (205) 373-8724 |
| Full Name | Fisher Dental Llc |
|---|---|
| Speciality | Clinic/center - Dental |
| Location | 106 5th St Ne, Aliceville, Alabama |
| Authorized Official Name and Position | Lillie Fisher (OWNER/DENTIST) |
| Authorized Official Contact | 2567141645 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Fisher Dental Llc 106 5th St Ne Aliceville AL 35442-2200 Ph: (205) 373-8726 | Fisher Dental Llc 106 5th St Ne Aliceville AL 35442-2200 Ph: (205) 373-8726 |
| NPI Number | 1144911785 |
|---|---|
| Provider Enumeration Date | 05/16/2023 |
| Last Update Date | 05/16/2023 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144911785 | NPI | - | NPPES |
| 219421 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | (* (Not Available)) | Primary |
News Archive
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.
Results of a genome-wide association study on 2,244 critically-ill patients due to coronavirus disease (COVID-19) from 208 intensive care units across the United Kingdom revealed significant host-specific genetic determinants that can predispose people to the severe form of the disease. The report is currently available on the medRxiv preprint server.
"Scientists, stymied for decades by the complexity of the human immunodeficiency virus, are making progress on several fronts in the search for a cure for HIV infections," but "a major stumbling block is the fact that HIV lies low in pools or reservoirs of latent infection that even powerful drugs cannot reach, scientists told the Conference on Retroviruses and Opportunistic Infections, one of the world's largest scientific meetings on HIV/AIDS," in Seattle last week, Reuters reports.
Pfizer Inc. announced today that the SUN 1087 trial of sunitinib in combination with erlotinib versus erlotinib demonstrated a statistically significant improvement in Progression-Free but not in Overall Survival in patients with previously treated advanced non-small cell lung cancer (NSCLC).
Research shows that people with a theoretical high risk of developing Parkinson's disease (PD) have significant cognitive deficits, particularly affecting executive function.
› Verified 7 days ago
James Emmett Gunnells, Dmd, Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 106 5th St Ne, Aliceville, AL 35442 Phone: 205-373-8726 |